CCL7 as a novel biomarker and adjuvant for immunocheckpoint blockade therapy to NSCLC
Bo Zhong and Man Zhang, Wuhan University
Nature Research Cancer Community is for all those interested in cancer research, including our journal readers and authors, educators, and those working in medicine, industry and healthcare